e-learning
resources
ERJ
2012
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
A breath test for malignant mesothelioma using an electronic nose
Chapman Eleanor A., Thomas Paul S., Stone Emily, Lewis Craig, Yates Deborah H.
Source:
Eur Respir J 2012; 40: 448-454
Journal Issue:
August
Disease area:
Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Chapman Eleanor A., Thomas Paul S., Stone Emily, Lewis Craig, Yates Deborah H.. A breath test for malignant mesothelioma using an electronic nose. Eur Respir J 2012; 40: 448-454
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Asbestosis
Diagnosis and staging of malignant pleural mesothelioma
Cisplatin/pemetrexed chemotherapy versus palliative care survival in malignant pleural mesothelioma
Related content which might interest you:
Volatile organic compounds increase the likelihood of detecting malignant pleural mesothelioma
Source: International Congress 2015 – Emerging technologies for malignant pleural diseases management
Year: 2015
LATE-BREAKING ABSTRACT: An electronic nose distinguishes the exhaled breath of patients with pleural malignant mesothelioma from subjects with professional asbestos exposure
Source: Annual Congress 2009 - Diagnosis and management of pleural effusions and mesothelioma: improving old techniques and new tools
Year: 2009
Chemical characterization of exhaled breath to discriminate patients with malignant pleural mesothelioma from subjects with similar professional asbestos exposure
Source: Annual Congress 2010 - Clinical diagnosis and management of malignant pleural effusions
Year: 2010
Exhaled breath analysis allows exclusive screening for malignant pleural mesothelioma.
Source: International Congress 2017 – Mesothelioma and malignant pleural disease
Year: 2017
Volatile organic compounds (VOC) in exhaled breath in patients with lung cancer, using the analytical technique thermal desorber- gase chromatography-spectrometer mases
Source: Annual Congress 2012 - New biomarkers for lung cancer
Year: 2012
Exhaled breath to screen for malignant pleural mesothelioma: a validation study
Source: Eur Respir J, 50 (6) 1700919; 10.1183/13993003.00919-2017
Year: 2017
Exhaled biomarkers in lung cancer
Source: Eur Respir J 2009; 34: 261-275
Year: 2009
Volatile organic compounds in the exhaled breath of young patients with cystic fibrosis
Source: Eur Respir J 2006; 27: 929-936
Year: 2006
Volatile organic compounds as an early diagnostic tool for malignant pleural mesothelioma
Source: International Congress 2014 – Diagnosis and treatment of pleural mesothelioma
Year: 2014
Drug repurposing in malignant pleural mesothelioma: a breath of fresh air?
Source: Eur Respir Rev, 27 (147) 170098; 10.1183/16000617.0098-2017
Year: 2018
Semi-volatile organic compounds in exhaled breath condensate: a new approach in the differential diagnosis of asthma and COPD
Source: Annual Congress 2009 - Asthma assessment and original therapeutic approaches
Year: 2009
Volatile organic compounds (VOC) in exhaled air sampled through the working channel of a bronchoscope in lung cancer patients
Source: Annual Congress 2010 - Recent developments of molecular pathology and functional genomics in non-neoplastic and neoplastic lung diseases
Year: 2010
An Investigation into the ability of people with lung disease to provide breath specimens using a roadside screening device and an evidential breath testing device.
Source: International Congress 2017 – Lung function testing
Year: 2017
Analysis of semi-volatile organic compounds in exhaled breath condensate of patients with obstructive lung diseases
Source: Annual Congress 2010 - COPD: systemic inflammation and comorbidities
Year: 2010
Volatile organic compounds in exhaled breath of patients with COPD ± lung cancer and their correlation with FEV1-values
Source: International Congress 2014 – The assessment of comorbidities
Year: 2014
The electronic nose: emerging biomarkers in lung cancer diagnostics
Source: Breathe, 15 (4) e135; 10.1183/20734735.0309-2019
Year: 2019
Differences in volatile organic compounds (VOC) determined in exhaled breath in two populations of lung cancer (LC): With and without COPD
Source: Annual Congress 2013 –New methods for diagnostic workup of lung cancer
Year: 2013
Integrating monitoring of volatile organic compounds (VOCs) in asthma and COPD into the routine lung function
Source: International Congress 2015 – The next generation of lung function tests
Year: 2015
Volatile organic compounds (VOCs) in exhaled air of patients with lung cancer
Source: Eur Respir J 2003; 22: Suppl. 45, 208s
Year: 2003
Exhaled volatile organic compounds as biomarkers for respiratory diseases
Source: Eur Respir Monogr 2010; 49: 130-139
Year: 2010
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept